Riveiro-Barciela, M.Alonso, SoniaFernández, InmaculadaRincón, D.Real, YolandaCrespo, JavierGea, F.Olveira, AntonioCalleja-Panero, José LuisPolo Lorduy, B.Carrión, José A.Arenas, JuanDevesa, M.J.Baliellas, CarmeCastro-Iglesias, ÁngelesRomero-Gómez, ManuelGranados, R.Pascasio Acevedo, Juan ManuelForns, XavierTurnes Vázquez, JuanMontero, J.L.Esteban, R.Fernández-Rodríguez, Conrado M.2019-02-152019-02-152016-10Riveiro-Barcela M, Alonso S, Fernández I, et al. Sofosbuvir/ledipasvir plus ribavirin achieves high SVR12 in genotype‐3 patients with compensated cirrhosis and similar to sofosbuvir plus daclatasvir: a multicentre real life cohort. En: The 67th Annual Meeting of the American Association for the Study of Liver Diseases: the Liver Meeting 2016; 2016 Nov 11-15; Boston, Massachusetts. Hoboken, NJ: John Wiley & Sons; 2016. p. 464A (Heaptology. 2016; 64 Special issue 1)0270-9139http://hdl.handle.net/2183/21786Poster abstractengThis is the peer reviewed version of the article which has been published in final form at Hepatology. This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for self-archivingconference outputopen access